Survey of sexually transmitted disease laboratory methods in US army laboratories

Sexually Transmitted Diseases

Volumn 37, Issue 1, 2010, Pages 44-48

  Lee, Seung Eun ^a,b   Nauschuetz, William ^c   Jordan, Nikki ^d   Lindler, Luther ^a   Steece, Richard ^e   Pfau, Esther ^d,f   Gaydos, Joel ^a  

^a Armed Forces Health Surveillance Center   (United States)

^b Found Advancement of Military Med   (United States)

^c US Army Dental Command   (United States)

^d U S ARMY CENTER FOR HEALTH PROMOTION AND PREVENTIVE MEDICINE   (United States)

^e National Infertility Prevention Project   (United States)

^f OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARMY; ARTICLE; CANCER CELL; CHLAMYDIA TRACHOMATIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENITAL HERPES; HEALTH SURVEY; HUMAN; LABORATORY; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION; PUBLIC HEALTH; QUESTIONNAIRE; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONAS; UNITED STATES; UTERINE CERVIX CANCER; VAGINITIS; WART VIRUS;

ADULT; CHLAMYDIA TRACHOMATIS; FEMALE; HEALTH CARE SURVEYS; HUMANS; LABORATORIES; MALE; MASS SCREENING; MILITARY PERSONNEL; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POPULATION SURVEILLANCE; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASES; UNITED STATES;

EID: 74249091560     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181b66dd6     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2006. Atlanta, GA: US Department of Health and Human Services, November 2007.
2. Centers for Disease Control and Prevention. Summary of notifiable diseases\-United States, 2006. MMWR Morb Mortal Wkly Rep 2008:55;1-92
3. Medical Surveillance Monthly Report. Reportable medical events, active and reserve components, US Armed Forces, 2008. 2004; 16:25.
4. Emerson LA. Sexually transmitted disease control in the armed forces, past and present. Mil Med 1997; 162:87-91.
5. US Census Bureau. Am FactFinder: 2008 population estimates. T6-2008: Sex by age. Available at: http://factfinder.census.gov/. Accessed June 1, 2009. Representation in the Military Services, 2005. Available at: http://www.defenselink.mil/prhome/poprep2005/ summary/summary.html. Accessed December 8, 2008.
6. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR 2006;55:(No.)
7. Defense medical epidemiology database. Available at: www.afhsc.mil. Accessed June 1, 2009.
8. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36:6-10.
9. US Preventive Services Task Force. Screening for chlamydial infection: U.S. preventive services task force recommendation statement. Ann Intern Med 2007; 147:128-135.
10. Cates W Jr, Rolfs R Jr, Aral S. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: An epidemiologic update. Epidemiol Rev 1990; 12:199-220.
11. Kohl K, Markowitz L, Koumans E. Developments in the screening for Chlamydia trachomatis: A review. Obstet Gynecol Clin North Am 2003; 30:637-658.
12. Holmes KK, Sparling PF, Stamm WE, et al. Sex Transmitted Diseases, 4th ed. Ch 52, New York, NY: Mcgraw Hill, 2008.
13. Olshen E, Shrier LA. Diagnostic tests for chlamydial and gonor-rheal infections. Semin Pediatr Infect Dis 2005; 16:192-198.
14. US Food and Drug Administration. Center for Devices and Radiological Health. Available at: http://www.accessdata.fda.gov/ scripts/cdrh/cfdocs/cfCLIA/ clia.cfm. Accessed December 5, 2008.
15. Herring A, Ballard R, Mabey D, et al. WHO/TDR Sexually Transmitted Disease Diagnostics Initiative. Evaluation of rapid diagnostic tests: Chlamydia and gonorrhoea. Nat Rev Microbiol 2006; 4(suppl 12):S41-S48.
16. Dicker LW, Mosure DJ, Steece R, et al. Testing for sexually transmitted diseases in U.S. public health laboratories in 2004. Sex Transm Dis 2007; 34:41-46.
17. Dicker LW, Mosure DJ, Steece R, et al. Laboratory tests used in U.S. public health laboratories for sexually transmitted diseases, 2000. Sex Transm Dis 2004; 31:259-264.
18. HQ, US Army Medical Command. Tri-service reportable events list. US Army Medical Command, Houston, TX, June 17, 1998. Available at: http://www.afhsc.mil/ Documents/medcom-memo.pdf.
19. Tri-Service reportable events: Guidelines and case definitions. Army Medical Surveillance Activity, Silver Spring, MD, May 2004. Available at: http://www.afhsc.mil/documents/DoD-PDFs/ May04TriServREGuide.pdf.
20. Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System. Available at: http://www.cdc.gov/ ncphi/disss/nndss/ nndsshis.htm. Accessed December 11, 2008.
21. Department of the Army. Army Regulation 40-45 Preventive Medicine. Department of Army, 25 May 2007. Available at: http://www.apd.army.mil/pdffiles/ r40-5.pdf.
22. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10:160-184.
23. Stamm WE. Toward control of sexually transmitted chlamydial infections. Ann Intern Med 1993; 119:432-434.
24. Centers for Disease Control and Prevention. Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006: Fluoroquinolones no longer recommended for treatment of gono-coccal infections. Morb Mortal Wkly Rep 2007:56; 332-336.
25. US Preventive Services Task Force. Screening for gonorrhea: Recommendation statement. US Preventive Services Task Force, Rockville, MD, May 2005. AHRQ Publication No. 05-0579A
26. US Preventive Services Task Force. Screening for cervical cancer. US Preventive Services Task Force, Rockville, MD, January 2003. AHRQ Publication No. 03-515A.
27. Gaydos CA, Howell MR, Quinn TC, et al. Sustained high prevalence of Chlamydia trachomatis infections in female army recruits. Sex Transm Dis 2003; 30:539-544.
28. Cecil JA, Howell MR, Tawes JJ, et al. Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male army recruits. J Infect Dis 2001; 184:1216-1219.
29. Chernesky MA, Jang DE. APTIMA transcription-mediated amplification assays for Chlamydia trachomatis and Neisseria gon-orrhoeae. Expert Rev Mol Diagn 2006; 6:519-525.
30. Levett PN, Brandt K, Olenius K, et al. Evaluation of three automated nucleic acid amplification systems for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in first-void urine specimens. J Clin Microbiol 2008; 46:2109-2111.
31. Niebuhr D, Tobler S, Jordan N, et al. Sexually transmitted infections among military recruits. In: DeKoning B, ed. Recruit Medicine. Falls Church, VA: Office of the Surgeon General, United States Army and Washington, DC: The Borden Institute, Walter Reed Army Medical Center, 2006:255-275.
32. Howell M, McKee K, Gaydos J, et al. Point-of-entry screening for C. trachomatis in female army recruits. Who derives the cost savings? Am J Prev Med 2000; 19:160-166.
33. Clark KL, Kelley PW, Mahmoud RA, et al. Cost-effective syphilis screening in military recruit applicants. Mil Med 1999; 164: 580-584.
34. Nevin R, Shuping E, Frick K, et al. Cost and effectiveness of Chlamydia screening among male military recruits: Markov modeling of complications averted through notification of prior female partners. Sex Transm Dis 2008; 35:705-713.